2B8T2M

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name2B8T2M
Drug Alias NameIL-15/CD20 tetravalent complex (Altor Bioscience)2B8T2M
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-15 receptors agonistsB-lymphocyte antigen CD20 inhibitors
TargetsInterleukin-15 receptorsB-lymphocyte antigen CD20
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAltor Bioscience Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAltor Bioscience Corp
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A